Table 1. Surface marker, tissue distribution, and transcriptional regulators of murine DC subsets.
DC subset | Surface markers | Tissue distribution | Transcription factor(s) requireda | References |
---|---|---|---|---|
pDC | CD11cloCD11b−B220+PDCA-1+ SiglecH+ | Lymphoid/nonlymphoid | E2-2, Gfi1, Ikaros, IRF4, IRF8, PU.1, STAT3 | [99, 100, 102–104, 106, 108, 238] |
cDC | ||||
CD8α+ | CD11chiMHCII+CD11bloCD4− CD8α+ | Lymphoid | Batf3, Gfi1, Id2, Ikaros, IRF8, PU.1 | [100, 102, 107, 108, 113, 215, 239, 240] |
CD8α− | CD11chiMHCII+CD11bhiCD8α− CD4+ or CD4− | Lymphoid | Gfi1, IRF2, IRF4, PU.1, RelB, RBP-J | [100, 108, 112, 119–122, 147] |
CD103+ | CD11c+MHCII+CD11bloCD103+ | Nonlymphoid; lymph nodes; lamina propriab | Batf3, IRF8, Id2 | [116, 118] |
CD103− | CD11c+MHCII+CD11bhiCD103− | Nonlymphoid; lamina propriab | Unknown | [117] |
LC | Langerin+MHCIIloCD11b+ CD207hiCD103− | Epidermis | Id2, IRF2, Runx3 | [113, 123, 147] |
While PU.1 function has not been determined in all DC subsets listed, it is expected to be required due to its role in mediating macrophage and DC development.
In mouse lamina propria, the CD103+ and CD103− DCs are further characterized based on their expression of M-CSFR and CX3CR1, including MHCIIhiCD11chiCD103+CD11b+ CX3CR1−M-CSFRlo, MHCIIhiCD11chiCD103−CD11b+CX3CR1+M-CSFRhi, MHCIIhiCD11chiCD103+CD11b−CX3CR1−M-CSFRlo, and MHCIIhiCD11cloCD103−CD11b+CX3CR1+M-CSFRhi [117].